The antimicrobial peptide cathelicidin drives development of experimental autoimmune encephalomyelitis in mice by affecting Th17 differentiation.
Multiple sclerosis (MS) is a highly prevalent demyelinating autoimmune condition; the mechanisms regulating its severity and progression are unclear. The IL-17-producing Th17 subset of T cells has been widely implicated in MS and in the mouse model, experimental autoimmune encephalomyelitis (EAE). H...
Saved in:
| Main Authors: | Katie J Smith, Danielle Minns, Brian J McHugh, Rebecca K Holloway, Richard O'Connor, Anna Williams, Lauren Melrose, Rhoanne McPherson, Veronique E Miron, Donald J Davidson, Emily Gwyer Findlay |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2022-08-01
|
| Series: | PLoS Biology |
| Online Access: | https://journals.plos.org/plosbiology/article/file?id=10.1371/journal.pbio.3001554&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The human cathelicidin LL-37 has antiviral activity against respiratory syncytial virus.
by: Silke M Currie, et al.
Published: (2013-01-01) -
Human cathelicidin production by the cervix.
by: Lorraine Frew, et al.
Published: (2014-01-01) -
Cathelicidin host defence peptide augments clearance of pulmonary Pseudomonas aeruginosa infection by its influence on neutrophil function in vivo.
by: Paula E Beaumont, et al.
Published: (2014-01-01) -
R‐flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice
by: Katja Schmitz, et al.
Published: (2014-09-01) -
Behavioral investigation of mice with experimental autoimmune encephalomyelitis
by: David Henrique Rodrigues, et al.
Published: (2011-12-01)